arrow
Return

Multiple Sclerosis Performance Test: Technical Development and Usability

delete2019-05-03
delete45
delete
OA
AI
J
Jane Rhodes
D
David Schindler
S
Stephen M. Rao
F
Fernando Venegas
E
Efrosini T. Bruzik
W
Wendy Gabel
J
James R. Williams
G
Glenn Phillips
C
Colleen C. Mullen
J
Jaime L. Freiburger
L
Lyla Mourany
C
Christine Reece
D
Deborah Miller
F
François Béthoux
R
Robert A Bermel
L
Lauren Krupp
E
Ellen M. Mowry
J
Jay L. Alberts
R
Richard A. Rudick *
DOI:10.1007/s12325-019-00958-xdelete
deleteOriginal
deleteShare
deleteSave
View PDF
Abstract

Abstract

En 中文
IntroductionIn the clinic, the assessment of patients with multiple sclerosis (MS) is typically qualitative and non-standardized.ObjectivesTo describe the MS Performance Test (MSPT), an iPad Air((R)) 2 (Apple, Cupertino, CA, USA)-based neurological assessment platform allowing patients to input relevant information without the aid of a medical technician, creating a longitudinal, clinically meaningful, digital medical record. To report results from human factor (HF) and usability studies, and the initial large-scale implementation in a practice setting.MethodsThe HF study examined use-error patterns in small groups of MS patients and healthy controls (n=14), the usability study assessed the effectiveness of patient interaction with the tool by patients with a range of MS disability (n=60) in a clinical setting, and the implementation study deployed the MSPT across a diverse population of patients (n=1000) in a large MS center for routine clinical care.ResultsMSPT assessments were completed by all users in the HF study; minor changes to design were recommended. In the usability study, 73% of patients with MS completed the MSPT, with an average administration time of 32min; 85% described their experience with the tool as satisfactory. In the initial implementation for routine care, 84% of patients with MS completed the MSPT, with an average administration time of 28min.ConclusionPatients with MS with varying disability levels completed the MSPT with minimal or no supervision, resulting in comprehensive, efficient, standardized, quantitative, clinically meaningful data collection as part of routine medical care, thus allowing for large-scale, real-world evidence generation.FundingBiogen.Trial RegistrationNCT02664324.
Keywords:
Digital assessment
Functional performance outcome measures
Multiple sclerosis
Multiple sclerosis functional composite
Neurology
Neuro-QoL
PerfOs
AI Summary

AI Summary

Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.

Journal

Advances in Therapy cover
Advances in Therapy
IF:
4
Papers:
4.6K
Citations:
1.0W

Organization

N
nyu langone medical center
Scholars:
1.1W
Papers: 6.5K
Citations: 11
B
Biogen
Scholars:
2.9K
Papers: 1.4K
Citations: 2
N
New York University
Scholars:
4.4W
Papers: 3.9W
Citations: 5.8W
J
Johns Hopkins University
Scholars:
10.2W
Papers: 8.8W
Citations: 13.0W
C
cleveland clinic foundation
Scholars:
3.7W
Papers: 3.0W
Citations: 29
researcher View more organizations
Cited Papers

Cited Papers

Neuro-QOL Brief measures of health-related quality of life for clinical research in neurology
err2012-06-05
err522
errOAAI
errCella, D.; Lai, J-S.; Nowinski, C. J.; Victorson, D.; Peterman, A.; Miller, D.; Bethoux, F.; Heinemann, A.; Rubin, S.; Cavazos, J. E.; Reder, A. T.; Sufit, R.; Simuni, T.; Holmes, G. L.; Siderowf, A.; Wojna, V.; Bode, R.; McKinney, N.; Podrabsky, T.; Wortman, K.; Choi, S.; Gershon, R.; Rothrock, N.; Moy, C.
errShare
errSave
Validity of low-contrast letter acuity as a visual performance outcome measure for multiple sclerosis
err2017-02-16
err139
errOAAI
errBalcer, Laura J.; Raynowska, Jenelle; Nolan, Rachel; Galetta, Steven L.; Kapoor, Raju; Benedict, Ralph; Phillips, Glenn; LaRocca, Nicholas; Hudson, Lynn; Rudick, Richard
errShare
errSave
Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis
err2017-02-16
err283
errOAAI
errMotl, Robert W.; Cohen, Jeffrey A.; Benedict, Ralph; Phillips, Glenn; LaRocca, Nicholas; Hudson, Lynn D.; Rudick, Richard
errShare
errSave
Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis
err2017-02-16
err585
errOAAI
errBenedict, Ralph H. B.; DeLuca, John; Phillips, Glenn; LaRocca, Nicholas; Hudson, Lynn D.; Rudick, Richard
errShare
errSave
The Nine-Hole Peg Test as a manual dexterity performance measure for multiple sclerosis
err2017-02-16
err335
errOAAI
errFeys, Peter; Lamers, Ilse; Francis, Gordon; Benedict, Ralph; Phillips, Glenn; LaRocca, Nicholas; Hudson, Lynn D.; Rudick, Richard
errShare
errSave
Validating Neuro-QoL short forms and targeted scales with people who have multiple sclerosis
err2015-08-03
err72
errOAAI
errMiller, Deborah M.; Bethoux, Francois; Victorson, David; Nowinski, Cindy J.; Buono, Sarah; Lai, Jin-Shei; Wortman, Katy; Burns, James L.; Moy, Claudia; Cella, David
errShare
errSave
Assessing changes in relapse rates in multiple sclerosis
err2010-09-01
err90
PREAI
errInusah, Seidu; Sormani, Maria P.; Cofield, Stacey S.; Aban, Inmaculada B.; Musani, Solomon K.; Srinivasasainagendra, Vinodh; Cutter, Gary R.
errShare
errSave
Defining the clinical course of multiple sclerosis The 2013 revisions
err2014-07-15
err2.4K
errOAAI
errLublin, Fred D.; Reingold, Stephen C.; Cohen, Jeffrey A.; Cutter, Gary R.; Sorensen, Per Soelberg; Thompson, Alan J.; Wolinsky, Jerry S.; Balcer, Laura J.; Banwell, Brenda; Barkhof, Frederik; Bebo, Bruce, Jr.; Calabresi, Peter A.; Clanet, Michel; Comi, Giancarlo; Fox, Robert J.; Freedman, Mark S.; Goodman, Andrew D.; Inglese, Matilde; Kappos, Ludwig; Kieseier, Bernd C.; Lincoln, John A.; Lubetzki, Catherine; Miller, Aaron E.; Montalban, Xavier; O'Connor, Paul W.; Petkau, John; Pozzilli, Carlo; Rudick, Richard A.; Sormani, Maria Pia; Stueve, Olaf; Waubant, Emmanuelle; Polman, Chris H.
errShare
errSave
researcher View more